Latest Financial Position News

Urbanise.com Limited reported a 12.4% revenue increase in Q1 FY2026, driven by its NAB partnership, while investing heavily in its Data and Payments Integration Services (DPIS) with expected cash outflows through FY2026.

IperionX has boosted titanium powder production capacity by 60% and secured US$75 million in Department of War funding to scale up to 1,400 tonnes per annum by 2027, aiming to become the largest and lowest-cost US titanium producer.

Clever Culture Systems reports a cashflow positive quarter, expanding its pharmaceutical customer base and launching a new contact plate analysis module that promises to drive recurring revenues.

Conico Ltd updates shareholders on a significant capital raising expansion, including a share consolidation and converting loan conversions to fund exploration at Mount Thirsty.

BluGlass Limited reports a robust project pipeline exceeding US$100 million, bolstered by initial orders from Collins Aerospace and Infleqtion Inc, alongside strategic board appointments and a $6 million R&D tax rebate.

Aurora Labs has advanced its micro gas turbine propulsion program with critical durability testing, a new Defence contract phase, and a strategic $5.5 million capital raise to scale manufacturing and commercialisation.

Encounter Resources has raised A$25 million through an institutional placement to fast-track its Aileron niobium-REE project and expand copper exploration across Western Australia and the Northern Territory.

Norwest Minerals advances its Bulgera Gold Project with successful deep drilling and promising heap leach economics, while preparing to test historic gold targets at Marymia East and expanding base metals exploration at Arunta West.

Way2VAT Ltd has completed its acquisition of RBC VAT Limited, boosting its European footprint and advisory services, while reporting a record quarterly revenue of A$1.89 million, up 34% year-on-year.

NeuroScientific Biopharmaceuticals has secured regulatory approval for initial patient treatments under its Special Access Program for StemSmart™ in Crohn’s disease, alongside key executive appointments and a manufacturing partnership to support upcoming clinical trials.

Australian Dairy Nutritionals reported a 66% year-on-year revenue increase in Q1 FY26, driven by strong nutritional powder sales and expanded distribution in China, while improving cash flow and production capacity.

Lynas Rare Earths delivered record quarterly sales revenue of A$200.2 million in Q1 FY26, bolstered by a successful $932 million equity raise and strategic partnerships aimed at securing critical rare earth supply chains outside China.